Status:
COMPLETED
Fusion Versus Cognitive MRI Targeted Prostatic Biopsy
Lead Sponsor:
Menoufia University
Conditions:
Prostatic Cancer
Eligibility:
MALE
Phase:
NA
Brief Summary
The aim of the present study is to compare the accuracy of Magnetic resonance imaging targeted (fusion) versus cognitive prostatic biopsy in biopsy-naïve suspected cancer prostate patient
Detailed Description
Prostate cancer is the second most frequent malignancy (after lung cancer) in men worldwide, counting 1,276,106 new cases and causing 358,989 deaths (3.8% of all deaths caused by cancer in men. The c...
Eligibility Criteria
Inclusion
- prostate biopsy-naïve men
- PSA levels of up to 20 ng/mL
- Multi-parametric prostate MRI revealed a PIRAD 4 or PIRAD 5.
Exclusion
- PSA level greater than 20 ng/mL
- patient with history of TRUS biopsy
- patient diagnosed as cancer prostate or with distant metastasis
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT05969704
Start Date
January 1 2023
End Date
December 31 2024
Last Update
January 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Menoufia University Hospital
Shibīn al Kawm, Menoufia, Egypt, 13829